We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLCM
1426
DELISTED
POLYCOM INC
PLCM
| $250K | 0.01% |
+19,948
| New | +$260K |
|
1427
Ligand Pharmaceuticals
LGND
$5.94B
| $249K | 0.01% |
+3,687
| New | +$228K |
|
1428
Monro
MNRO
$537M
| $249K | 0.01% |
+3,765
| New | +$268K |
|
|
PLKI
1429
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $249K | 0.01% |
+4,250
| New | +$241K |
|
1430
Ally Financial
ALLY
$13.4B
| $248K | 0.01% |
13,288
-8,890
| -40% | -$176K |
|
1431
Carter's
CRI
$1.45B
| $248K | 0.01% |
2,780
-4,674
| -63% | -$417K |
|
1432
OFG Bancorp
OFG
$2.24B
| $247K | 0.01% |
+33,711
| New | +$289K |
|
1433
Plexus
PLXS
$6.69B
| $247K | 0.01% |
+7,071
| New | +$264K |
|
|
LTXB
1434
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $247K | 0.01% |
+9,872
| New | +$284K |
|
|
SCMP
1435
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $247K | 0.01% |
+14,291
| New | +$256K |
|
1436
Mid-America Apartment Communities
MAA
$15.8B
| $245K | 0.01% |
2,700
-1,074
| -28% | -$93.3K |
|
1437
Ubiquiti
UI
$32.4B
| $245K | 0.01% |
+7,730
| New | +$256K |
|
1438
OneMain Financial
OMF
$7.19B
| $244K | 0.01% |
+5,881
| New | +$270K |
|
|
TMHC
1439
DELISTED
Taylor Morrison
TMHC
| $244K | 0.01% |
+15,231
| New | +$268K |
|
1440
Wells Fargo
WFC
$263B
| $244K | 0.01% |
4,484
-19,413
| -81% | -$1.05M |
|
|
VR
1441
DELISTED
Validus Hold Ltd
VR
| $244K | 0.01% |
5,258
-23,117
| -81% | -$1.05M |
|
|
JNS
1442
DELISTED
Janus Capital Group Inc
JNS
| $244K | 0.01% |
+17,335
| New | +$258K |
|
1443
Camden Property Trust
CPT
$11.4B
| $243K | 0.01% |
+3,155
| New | +$240K |
|
1444
First Bancorp
FBP
$4.47B
| $243K | 0.01% |
+74,869
| New | +$277K |
|
|
HI
1445
DELISTED
Hillenbrand
HI
| $243K | 0.01% |
8,191
-19,068
| -70% | -$560K |
|
1446
Crown Castle
CCI
$33.1B
| $242K | 0.01% |
2,802
-7,502
| -73% | -$637K |
|
|
CFNL
1447
DELISTED
Cardinal Financial Corp
CFNL
| $242K | 0.01% |
+10,663
| New | +$251K |
|
1448
CF Industries
CF
$18.9B
| $241K | 0.01% |
5,913
-70,721
| -92% | -$3.33M |
|
1449
East-West Bancorp
EWBC
$18B
| $241K | 0.01% |
5,788
-11,366
| -66% | -$467K |
|
1450
Hormel Foods
HRL
$14.1B
| $241K | 0.01% |
+6,094
| New | +$217K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.